{"id":253419,"title":"Notice Regarding Interim Approach for Evaluating Cardiovascular Risk for New Antidiabetic Therapies to Treat Type 2 Diabetes Mellitus - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T17:10:47.265000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/interim-approach-evaluating-cardiovascular-risk-new-antidiabetic-therapies-treat-type-2-diabetes-mellitus-notice.html","snippet":"Notice Regarding Interim Approach for Evaluating Cardiovascular Risk for New Antidiabetic Therapies to Treat Type 2 Diabetes Mellitus - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search…","rawSnapshotUrl":"/api/snapshots/raw/253419","browseUrl":"https://replay.healtharchive.ca/job-1/20250418171047/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/interim-approach-evaluating-cardiovascular-risk-new-antidiabetic-therapies-treat-type-2-diabetes-mellitus-notice.html#ha_snapshot=253419","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}